1. Home
  2. EVI vs RNA Comparison

EVI vs RNA Comparison

Compare EVI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$17.89

Market Cap

204.6M

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$9.16

Market Cap

222.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
RNA
Founded
1959
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
222.5M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
EVI
RNA
Price
$17.89
$9.16
Analyst Decision
Strong Buy
Buy
Analyst Count
1
20
Target Price
$35.00
$69.26
AVG Volume (30 Days)
43.4K
336.2K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
1.81%
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
$389,830,000.00
N/A
Revenue This Year
$15.53
$88.12
Revenue Next Year
$3.83
$18.11
P/E Ratio
$36.82
N/A
Revenue Growth
10.26
N/A
52 Week Low
$12.75
$8.66
52 Week High
$34.75
$73.06

Technical Indicators

Market Signals
Indicator
EVI
RNA
Relative Strength Index (RSI) 71.62 29.37
Support Level $16.41 N/A
Resistance Level $21.36 $14.39
Average True Range (ATR) 1.09 0.77
MACD 0.41 -0.40
Stochastic Oscillator 93.57 9.27

Price Performance

Historical Comparison
EVI
RNA

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: